EQS-News: Redcare Pharmacy: shop-apotheke.com among Germany’s leading digital health platforms.
|
EQS-News: Redcare Pharmacy N.V.
/ Key word(s): Miscellaneous
Redcare Pharmacy: shop-apotheke.com among Germany’s leading digital health platforms. Sevenum, the Netherlands, June 25, 2026 – Redcare Pharmacy continues to strengthen its leading position in the German digital healthcare market. Shop Apotheke is currently the most visited health website in Germany and is also recognized for its quality, user experience and brand trust. This is confirmed by several recent awards and market studies. According to Similarweb, shop-apotheke.com is currently the highest-reaching health website in Germany¹. This highlights the growing importance of digital healthcare services and the central role Shop Apotheke now plays in consumers’ healthcare journeys. “We are witnessing a clear structural shift in the healthcare market. More and more people are managing their health digitally – quickly, conveniently and reliably. The fact that Shop Apotheke is now Germany’s most widely used digital health platform, while also being recognized as a leader in quality and trust, demonstrates that we are actively shaping this transformation,” said Olaf Heinrich, CEO of Redcare Pharmacy. In addition to its strong reach, Shop Apotheke also stands out for the quality of its offering. In the 2026 “App of the Year” study conducted by WirtschaftsWoche and Innofact, the Shop Apotheke app was named the best app in the online pharmacy category². Furthermore, shop-apotheke.com received an “Excellent” rating for technical quality and user experience in the “Top Shops 2026” ranking by COMPUTER BILD and Statista³. Key brand metrics also underline the company’s strong market position. In SEMPORA’s 2026 OTC and Pharmacy Market Study⁴, Redcare Pharmacy and shop-apotheke.com once again ranked among the best-known online pharmacies in Germany, achieving 83% brand awareness. In addition, the company ranked first among competitors in both purchase preference and perceived healthcare expertise. ¹ Similarweb, “Top Websites Germany – Health,” Germany ranking by website traffic, accessed June 2026: ² WirtschaftsWoche & Innofact, “App Ranking 2026: Germany’s Favorite Apps,” Online Pharmacy category, published 2026: ³ COMPUTER BILD & Statista, “Top Shops 2026,” recognition for technical quality and user experience, published March 2026: ⁴ SEMPORA Consulting, OTC and Pharmacy Market Study Germany 2026: Investor Relations contact: Irina Zhurba (Director, Investor Relations) Press contact: Sven Schirmer (Director, Corporate Communications) ___ About Redcare Pharmacy. Originally founded in 2001, Redcare Pharmacy N.V., with EUR 2.9B in revenues in 2025, is the leading online pharmacy in Europe and active in seven countries (Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland). Headquartered in the Netherlands, Redcare Pharmacy offers its over 14 million active customers more than 500,000 different healthcare-related products. Besides OTC drugs, nutritional supplements, beauty and personal care products, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands, operating as a true one-stop pharmacy. As the pharmacy of the future, Redcare stands for comprehensive pharmaceutical services for its customers – with pharmaceutical safety always being the top priority. Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the MDAX.
25.06.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2353890 |
| End of News | EQS News Service |
|
|
2353890 25.06.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 968,06 | 1.060,32 | 1.204,35 | 1.798,76 | 2.370,58 | 2.940,90 | 3.425,00 | |
| EBITDA1,2 | 15,20 | -38,73 | -29,66 | 39,99 | 29,23 | 47,40 | 81,00 | |
| EBITDA-Margin3 | 1,57 | -3,65 | -2,46 | 2,22 | 1,23 | 1,61 | 2,37 | |
| EBIT1,4 | -0,87 | -65,70 | -69,17 | -17,30 | -38,99 | -28,50 | 9,00 | |
| EBIT-Margin5 | -0,09 | -6,20 | -5,74 | -0,96 | -1,65 | -0,97 | 0,26 | |
| Net Profit (Loss)1 | -16,77 | -74,19 | -77,65 | -11,61 | -46,36 | -39,40 | -15,00 | |
| Net-Margin6 | -1,73 | -7,00 | -6,45 | -0,65 | -1,96 | -1,34 | -0,44 | |
| Cashflow1,7 | 17,80 | 11,64 | -29,11 | 61,46 | 22,13 | 31,00 | 39,00 | |
| Earnings per share8 | -1,17 | -4,15 | -4,32 | -0,73 | -2,27 | -1,87 | -0,73 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Forvis Mazars
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Redcare Pharmacy | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2AR94 | NL0012044747 | N.V. | 1.270,72 Mio € | 13.10.2016 | Halten | 9F3893WC+F5 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 37,42 | 0,00 | 0,00 | -32,95 | 2,77 | 40,99 | 0,43 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 15.04.2026 | 06.05.2026 | 29.07.2026 | 29.10.2026 | 04.03.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +6,25% | +5,59% | -6,23% | -37,69% | +120,54% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
